Trial Profile
Ascending Single Dose Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HTC-867 Administered Orally to Healthy Japanese Male Subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs HTC 867 (Primary)
- Indications Cognition disorders
- Focus Adverse reactions
- 31 Dec 2010 New trial record